Regen BioPharma Inc RGBP:OTCPK

*Data is delayed | Exchange | USD
Last | 2:51 PM EDT
0.6901UNCH (UNCH)
Volume
542
52 week range
0.40 - 2.55
Loading...
  • Open0.7001
  • Day High0.7001
  • Day Low0.6901
  • Prev Close0.6901
  • 52 Week High2.55
  • 52 Week High Date05/17/23
  • 52 Week Low0.40
  • 52 Week Low Date04/10/24

Key Stats

  • Market Cap2.839M
  • Shares Out4.11M
  • 10 Day Average Volume7,280.33
  • Dividend-
  • Dividend Yield-
  • Beta2.76
  • YTD % Change-27.36

KEY STATS

  • Open0.7001
  • Day High0.7001
  • Day Low0.6901
  • Prev Close0.6901
  • 52 Week High2.55
  • 52 Week High Date05/17/23
  • 52 Week Low0.40
  • 52 Week Low Date04/10/24
  • Market Cap2.839M
  • Shares Out4.11M
  • 10 Day Average Volume7,280.33
  • Dividend-
  • Dividend Yield-
  • Beta2.76
  • YTD % Change-27.36

RATIOS/PROFITABILITY

  • EPS (TTM)-0.23
  • P/E (TTM)-3.00
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-368,079.99
  • ROE (TTM)-
  • Revenue (TTM)236,579.999
  • Gross Margin (TTM)-
  • Net Margin (TTM)-378.93%
  • Debt To Equity (MRQ)-13.40%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Regen BioPharma Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Regen BioPharma Inc. is a biotechnology company. The Company is engaged on the immunology and immunotherapy space. The Company is focused on novel technologies through pre-clinical and Phase I/ II clinical trials. It is involved on mRNA and small molecule therapies for treating cancer and autoimmune disorders. It is also developing products treating blood disorders using small molecules and gene silencing (DiffronC), treating cancer with cellular immunotherapy (dCellVax...
David Koos M.D.
Chairman of the Board, President, Chief Executive Officer, Treasurer, Secretary
Address
4700 Spring Street, Suite 304
La Mesa, CA
91942
United States